Evidence missing to support moving ESRD patients into HMOs
Charytan, C.
Nephrology News and Issues 14(8): 13-14
2000
ISSN/ISBN: 0896-1263 PMID: 12101515 Document Number: 513749
Document emailed within 1 workday
Related Documents
Langley, C.L.; Lapidos-Salaiz, I.; Hamm, T.E.; Bateganya, M.H.; Firth, J.; Wilson, M.; Martin, J.; Dierberg, K. 2015: Prioritizing HIV care and support interventions-moving from evidence to policy Journal of Acquired Immune Deficiency Syndromes 68(Suppl 3): S375-S378Rocco, M.V.; Frankenfield, D.L.; Frederick, P.R.; Pugh, J.; McClellan, W.M.; Owen, W.F. 2000: Intermediate outcomes by race and ethnicity in peritoneal dialysis patients: results from the 1997 ESRD Core Indicators Project. National ESRD Core Indicators Workgroup Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 20(3): 328-335
Lavis, J.N.; Permanand, G.; Oxman, A.D.; Lewin, S.; Fretheim, A. 2009: SUPPORT Tools for evidence-informed health Policymaking (STP) 13: Preparing and using policy briefs to support evidence-informed policymaking Health Research Policy and Systems 7 Suppl. 1: S13
Pugh, J. 1995: Minorities and ESRD. Part I. Tracking the causes of ESRD in the Hispanic population Nephrology News and Issues 9(9): 34
Novelli, T. 2009: The US market: moving towards greater evidence-based pricing Medical Device Technology 20(3): 50-51
Lavis, J.N.; Wilson, M.G.; Oxman, A.D.; Lewin, S.; Fretheim, A. 2009: SUPPORT Tools for evidence-informed health Policymaking (STP) 4: Using research evidence to clarify a problem Health Research Policy and Systems 7(Suppl 1): S4
Lewin, S.; Oxman, A.D.; Lavis, J.N.; Fretheim, A.; Garcia Marti, S.; Munabi-Babigumira, S. 2009: SUPPORT tools for evidence-informed policymaking in health 11: Finding and using evidence about local conditions Health Research Policy and Systems 7(Suppl 1): S11
Oxman, A.D.; Lavis, J.N.; Fretheim, A.; Lewin, S. 2009: SUPPORT Tools for evidence-informed health Policymaking (STP) 17: Dealing with insufficient research evidence Health Research Policy and Systems 7(Suppl 1): S17
Eckerman, I. 1996: Efficiency differences between the public and the private sector? Evidence is missing! Lakartidningen 93(42): 3659-3660
Oxman, A.D.; Fretheim, A.; Lavis, J.N.; Lewin, S. 2009: SUPPORT Tools for evidence-informed health Policymaking (STP) 12: Finding and using research evidence about resource use and costs Health Research Policy and Systems 7(Suppl 1): S12
Oxman, A.D.; Lavis, J.N.; Fretheim, A.; Lewin, S. 2009: SUPPORT Tools for evidence-informed health Policymaking (STP) 16: Using research evidence in balancing the pros and cons of policies Health Research Policy and Systems 7(Suppl 1): S16
Fikree, F.F. 2013: Family planning in Pakistan--moving evidence to programmatic action Jpma. Journal of the Pakistan Medical Association 63(4 Suppl. 3): S1-S2
Larsson, A. 2006: Good evidence for benefits of cholinesterase inhibitors in Parkinson dementia is still missing Lakartidningen 103(19): 1537; Discussion: 1537-1538
Ilkhanoff, L.; Carver, J. 2005: Contrast-induced nephropathy and cardiac catheterization: evidence in support of using the iso-osmolar contrast agent iodixanol in patients with renal dysfunction Journal of Invasive Cardiology 17(4): 216-217
Lameire, N. 2000: Cardiovascular problems in ESRD patients Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 20(Suppl 3): 33-40
1998: 1998 camps for patients with ESRD Nephrology News and Issues 12(3): 16-7 19-20
Wish, J.B. 1997: How will we manage ESRD patients in the future? Nephrology News and Issues 11(11): 22-23
Aoki, M.; Han, X.Y.; Yamada, H.; Muto, T.; Satake, H.; Ito, Y.; Matsunami, K. 2000: Antigraviceptive neck muscle responses to "moving up and moving down" in human Journal of Gravitational Physiology: a Journal of the International Society for Gravitational Physiology 7(2): P111-P112
Chiang, H.C. 1996: Searching for the meaning of life of ESRD patients Hu Li Za Zhi Journal of Nursing 43(4): 92-96
Thervet, E. 2006: Organ transplantation in diabetics patients with ESRD Nephrologie and Therapeutique 2(Suppl 1): S63-S65